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Background: Newcastle disease is still a serious disease of poultry especially in backyard free-range production
systems despite the availability of cross protective vaccines. Healthy-looking poultry from live bird markets have
been suspected as a major source of disease spread although limited studies have been conducted to ascertain
the presence of the virulent strains in the markets and to understand how they are related to outbreak strains.
Methods: This study evaluated the occurrence of Newcastle disease virus in samples collected from poultry in
live bird markets across Uganda. The isolates were pathoyped using standard methods (mean death time (MDT),
intracelebral pathogenicity index (ICPI), and sequencing of the fusion protein cleavage site motif) and also
phylogenetically analysed after sequencing of the full fusion and hemagglutin-neuraminidase genes. The isolates
were classified into genotypes and subgenotypes based on the full fusion protein gene classification system and
compared with other strains in the region and world-wide.
Results: Virulent avian paramyxovirus type I (APMV-1) (Newcastle disease virus) was isolated in healthy-looking
poultry in live bird markets. The viruses belonged to a new subgenotype, Vd, in genotype V, and clustered together
with Tanzania and Kenya strains. They harbored low genetic diversity.
Conclusion: The occurrence of virulent AMPV-1 strains in live bird markets may serve as sources of Newcastle
disease outbreaks in non-commercial farms.
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Newcastle disease is a highly contagious disease affecting
chickens and other poultry species and wild birds. It
devastates unvaccinated flocks in periodic outbreaks
resulting in up to 70-100% mortality, which is a big loss
to the households. It is caused by RNA viruses of the
Avian Paramyxovirus type 1 (APMV-1), (synonym:
Newcastle disease virus, NDV) [1]. Based on clinical signs,
these viruses have been grouped by virulence phenotypes:
asymptomatic, lentogenic, mesogenic, and velogenic strains
reflecting increasing levels of virulence. Velogens, the most* Correspondence: dkb@covab.mak.ac.ug; m.ducatez@envt.fr
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article, unless otherwise stated.virulent viruses, are those that may cause extensive
hemorrhagic lesions, particularly in the gastrointestinal
tract (viscerotropic), and/or a predominance of nervous
signs (neurotropic) as well as respiratory signs. The lento-
genic strains are common among domestic poultry and
wild bird populations with insignificant clinical symptoms.
Although the disease is endemic in most African
countries, there are still limited studies regarding the
ecology, molecular epidemiology, genetic diversity, and
distribution of NDV on the continent, not to mention
the gap in field vaccine efficacy studies. Most research
has focused mainly on basic epidemiology especially dur-
ing ND outbreaks in poultry and it is believed ND in vil-
lage chickens is attributed to birds that are shedding
virus during and after incubation or post vaccination
[2,3]. It is thought that while vaccination conferstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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appearing healthy. It has been suggested that outbreaks
in the dry season are not due to better virus survival
under these conditions but to higher trading of birds
during this period [4]. Markets may serve as a source of
Newcastle disease infection and contribute to its spread
as infected birds not showing clinical signs are sold be-
fore they come down with the disease.
Genetically, NDV strains are broadly divided into
avirulent and virulent subtypes on the basis of the pre-
cursor fusion (F) protein cleavage activation site that
must be cleaved into F1 and F2 in order for the virus to
be infectious. The virulent strains have more basic
amino acids than their avirulent counterparts: 112(R/K)
RQ(R/K)R*F117 and 112(G/E)(K/R)Q(G/E)R*L117 mo-
tifs at the cleavage site for virulent and avirulent viruses,
respectively [5]. Biologically the virulent forms by inter-
national agreement for purposes of trade [5] are deter-
mined with intracerebral pathogenicity indices (ICPI)
of ≥ 0.7 but they can also be evaluated by mean death
time (MDT) and intravenous pathogenicity index (IVPI)
methods.
The genetic classification of the APMV-1 continues to
evolve. The simultaneous use of two systems for geno-
typing APMV-1 created some confusion and lineages
and genotypes classification have been reported under
different systems. Aldous et al. described a clustering
method for the APMV-1 based on the precursor fusion
protein cleavage activation site [6]. Recently a more ra-
tional genotyping method was proposed by Diel et al.
based on mean interpopulational evolutionary distances
of the full F protein with cutoff values to assign new
genotypes (>10% mean interpopulational evolutionary
distance) and new sub-genotypes (3 to 10% mean
interpopulational evolutionary distance) [7]. While both
systems agree to class I viruses having a single lineage,
the class II under Diel et al. contained 15 genetic groups
including 10 previously established (I-IX, and XI) and
five new genotypes (X, XII, XIII, XIV and XV) [7]. This
new unified nomenclature system is expected to provide
a clearer and more uniform classification system of
NDV isolates and facilitate common understanding of
the NDV epidemiology, evolution, disease control and
diagnosis. The drawback is that it requires extra work to
obtain the F gene full sequences.
Genotyping based on other APMV-1 genes still concur
with the basic grouping into classes I and II with class II
viruses comprising the vast majority of sequenced NDV.
This includes most of the virus isolates recovered from
poultry (gallinaceous birds) and from pet and wild
birds [8]. Phylogenetic studies of both the F and the
hemagglutinin-neuraminidase (HN) protein genes of
NDV have been used for most molecular epidemiologic
analyses and characterization of NDV into specificlineages [9] even prior to the proposed Diel at al. classi-
fication [7]. Restriction enzyme site mapping of the F
protein gene and sequence analysis have also been used
to classify NDV isolates into seven genotypes and was
the basis for identification of a novel genotype of NDV
isolates from Uganda reported in 2004 [10]. Different
lineages have been described in many parts of Africa
basing on the fusion protein cleavage site [6] and a few
are beginning to use the system described by Diel et al.,
[7,11,12]. Snoeck et al. thus recently completed the clas-
sification by Diel et al. [7] on the same criteria and
showed that 17 NDV class II genotypes (named I to
XVIII but with no genotype XV) co-circulate worldwide
[11]. The purpose of this study was to assess the occur-
rence of NDV pathotypes in live bird markets across
Uganda and to determine their genetic diversity and re-
latedness using the new NDV nomenclature.
Results and discussion
In total, 1,357 samples were collected from which 114
isolates were recovered (8.7% prevalence by isolation)
during the study period and only 19 paired samples
yielded virus from both tracheal and cloacal swabs. The
isolates were recovered in almost all the markets across
the country (Figure 1). The northern region had the
highest isolation rate of 22.1%, followed by central re-
gion at 13.1%, then the eastern region at 11.2% and the
lowest prevalence was in the western region at 6.9%.
Most of these markets sold chickens and indeed most
of the isolates (109 isolates from 1250 chicken samples;
8.7% isolation rate) were from chickens. Only two iso-
lates were obtained from thirty four turkeys samples
(5.8%) (NDV/turkey/Uganda/MU041/2011 and NDV/
turkey/Uganda/MU042/2011) and three isolates from
seventy three ducks samples (5.2%) (NDV/duck/Uganda/
MU062/2011, NDV/duck/Uganda/MU078/2011 and NDV/
duck/Uganda/MU079/2011). None of the turkeys or ducks
was showing any signs of disease at the time of sample col-
lection, while some of the chickens were showing symp-
toms of ND at the time of sample collection with an
isolation rate of 28.6% (6/21) and 9.0% (108/1229) from sick
and healthy chickens respectively.
Biological characterization of isolates
Intracelebral pathogenicity indices (ICPI) and mean death
time (MDT) methods demonstrated that all the isolates
were virulent with variations in virulence. According to
the values of 112 isolates on which MDT was performed,
most of the isolates (85%: 95/112) were velogenic while
the remaining (15%: 17/112) were mesogenic (only data
values for isolates for which full sequences for either F or
HN or both genes are shown in Table 1, the rest of the
data is not shown). According to ICPI values, all the iso-
lates had very high values ranging from 1.60- 1.86 (except
NDV with HN and/or F 
gene fully sequenced
Figure 1 Areas in Uganda (East Africa) where samples were collected. The map shows the distribution of representative isolates that
were sequenced throughout the country. The green spheres show area of origin and number of samples while the red triangles show
where sequence data originated.
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0.35) indicating that they were highly virulent. The isolates
were further assessed by examining the amino acids se-
quences of the fusion protein (F0) at position 112–117 at
the cleavage site and all had a “112RRQKR*F117” motif
which confirmed them as virulent (Table 1).
Phylogenetics analysis of Ugandan NDV isolates
A total of 49 representative isolates were fully sequenced
for either F (29 isolates) or HN (38 isolates) genes. Ofthese, 19 isolates were sequenced for both F and HN
genes. All the 49 isolates were sequenced for the cleav-
age site of the F gene and all harbored a multibasic
“112RRQKR*F117” motif at the site, suggesting a velogenic
phenotype. These isolates also had a valine amino acid
(aa) at position 118, and clustered with genotype V vi-
ruses [7,11] which corresponds to lineage 3c according
to Aldous et al. [6] and the few previously available
Ugandan NDV sequences for both their F (Figure 2) and
HN (Figure 3) genes.
Table 1 Biological characteristics of NDV isolated in this study
Isolate number District oforigin MDT (hrs) ICPI





full F gene Pathotype
NDV/chicken/Uganda/MU001/2011 MASAKA 46.2 1.75 GRRQKR’FV HG937535 HG937567 V
NDV/chicken/Uganda/MU004/2011 MASAKA 46.4 1.76 GRRQKR’FV 1 2 V
NDV/chicken/Uganda/MU005/2011 MASAKA 47.8 1.77 GRRQKR’FV 1 2 V
NDV/chicken/Uganda/MU007/2011 MASAKA 46 1.76 GRRQKR’FV HG937536 HG937568 V
NDV/chicken/Uganda/MU009/2011 MASAKA 48 1.78 GRRQKR’FV HG937537 HG937569 V
NDV/chicken/Uganda/MU010/2011 MASAKA 46.8 1.79 GRRQKR’FV HG937538 HG937570 V
NDV/chicken/Uganda/MU013/2011+ MUKONO 80.1 0.35 GRRQKR’FV HG937539 HG937571 M
NDV/chicken/Uganda/MU014/2011* MUKONO 54.2 1.77 GRRQKR’FV HG937540 V
NDV/chicken/Uganda/MU019/2011 WAKISO 68.8 1.68 GRRQKR’FV HG937541 HG937572 M
NDV/chicken/Uganda/MU022/2011* ABIM 44.8 1.77 GRRQKR’FV HG937542 V
NDV/chicken/Uganda/MU024/2011 ABIM ND ND GRRQKR’FV HG937573
NDV/chicken/Uganda/MU026/2011 BUGIRI 74.5 1.61 GRRQKR’FV HG937543 HG937574 M
NDV/chicken/Uganda/MU028/2011 BUGIRI 40.2 1.79 GRRQKR’FV 3 4 V
NDV/chicken/Uganda/MU029/2011* BUGIRI 40.1 1.78 GRRQKR’FV HG937544 V
NDV/chicken/Uganda/MU030/2011* IGANGA 36.8 1.78 GRRQKR’FV HG937545 V
NDV/chicken/Uganda/MU031/2011* IGANGA 46.9 1.78 GRRQKR’FV HG937546 V
NDV/chicken/Uganda/MU032/2011 IGANGA 36.8 1.77 GRRQKR’FV HG937575 V
NDV/chicken/Uganda/MU033/2011 IGANGA 40.2 1.78 GRRQKR’FV HG937576 V
NDV/chicken/Uganda/MU035/2011 IGANGA 44.2 1.75 GRRQKR’FV HG937547 HG937577 V
NDV/chicken/Uganda/MU037/2011 KOTIDO 68.2 1.7 GRRQKR’FV HG937578 M
NDV/chicken/Uganda/MU038/2011* KOTIDO 71.2 1.69 GRRQKR’FV M
NDV/chicken/Uganda/MU039/2011 KUMI 48.6 1.7 GRRQKR’FV HG937548 HG937579 V
NDV/chicken/Uganda/MU040/2011 KUMI 58.9 ND GRRQKR’FV HG937580 V
NDV/chicken/Uganda/MU044/2011 NAMUTUMBA 56.8 1.66 GRRQKR’FV HG937581 V
NDV/chicken/Uganda/MU050/2011 ARUA 50.6 1.75 GRRQKR’FV HG937582 V
NDV/chicken/Uganda/MU052/2011* ARUA 38.4 1.8 GRRQKR’FV HG937550 V
NDV/chicken/Uganda/MU054/2011* ARUA 38.4 1.82 GRRQKR’FV HG937551 V
NDV/chicken/Uganda/MU056/2011 ARUA 54.4 1.67 GRRQKR’FV HG937552 HG937583 V
NDV/chicken/Uganda/MU058/2011* ARUA 34.6 1.78 GRRQKR’FV HG937535 V
NDV/chicken/Uganda/MU059/2011* ARUA 48.2 1.76 GRRQKR’FV HG937553 V
NDV/duck/Uganda/MU062/2011 ARUA 58 1.74 GRRQKR’FV HG937584 V
NDV/chicken/Uganda/MU063/2011 ARUA 48.6 1.76 GRRQKR’FV 5 V
NDV/chicken/Uganda/MU069/2011 KIRYANDONGO 42.3 1.79 GRRQKR’FV HG937554 HG937585 V
NDV/chicken/Uganda/MU071/2011 KIRYANDONGO 48.8 1.75 GRRQKR’FV HG937555 HG937586 V
NDV/chicken/Uganda/MU072/2011* KIRYANDONGO 38.2 1.79 GRRQKR’FV HG937556 V
NDV/chicken/Uganda/MU074/2011 KOBOKO 48.2 1.77 GRRQKR’FV HG937557 HG937587 V
NDV/chicken/Uganda/MU077/2011* KOBOKO 51.1 1.75 GRRQKR’FV HG937558 V
NDV/chicken/Uganda/MU083/2011* NEBBI 48.2 1.76 GRRQKR’FV HG937559 V
NDV/chicken/Uganda/MU084/2011 NEBBI 64.2 1.62 GRRQKR’FV HG937560 HG937588 M
NDV/chicken/Uganda/MU090/2011 GULU 46.2 1.77 GRRQKR’FV HG937561 HG9375689 V
NDV/chicken/Uganda/MU091/2011* GULU 44.3 1.83 GRRQKR’FV HG937562 V
NDV/chicken/Uganda/MU096/2011* GULU 56.5 ND GRRQKR’FV HG937563 V
NDV/chicken/Uganda/MU098/2011* GULU 44.2 1.77 GRRQKR’FV HG937564 V
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Table 1 Biological characteristics of NDV isolated in this study (Continued)
NDV/chicken/Uganda/MU099/2011* GULU 50.2 1.75 GRRQKR’FV 6 V
NDV/chicken/Uganda/MU102/2011* GULU 37.6 1.79 GRRQKR’FV 7 V
NDV/chicken/Uganda/MU105/2011* GULU 55.7 1.74 GRRQKR’FV 7 V
NDV/chicken/Uganda/MU108/2011* KABALE 49.8 1.72 GRRQKR’FV HG937565 V
NDV/chicken/Uganda/MU111/2011 KASESE 52.1 1.86 GRRQKR’FV HG937566 HG937590 V
NDV/chicken/Uganda/MU113/2011 KASESE 56.4 ND GRRQKR’FV HG937591 V
The table presents isolates for which full HN or F genes or both were sequenced. ND = Not done; V = velogenic; M =mesogenic; the pathotype was based on MDT
values as described in materials and methods; *only partial F gene sequences were obtained for these isolates with FIP1-FIP2 primers targeting the F cleavage site
area(Kho, Mohd-Azmi et al. [32]). 1HN gene sequences identical to HN of NDV/chicken/Uganda/MU001/2011 (accession number: HG937535); 2 F gene sequences
identical to F of NDV/chicken/Uganda/MU001/2011 (accession number: HG937567); 3HN gene sequences identical to HN of NDV/chicken/Uganda/MU026/2011
(accession number: HG937543); 4 F gene sequences identical to F of NDV/chicken/Uganda/MU026/2011(accession number: HG937574); F gene sequence identical
to F of NDV/duck/Uganda/MU062/2011 (accession number: HG937584); HN gene sequences identical to HN of NDV/chicken/Uganda/MU096/2011 (accession
number: HG937563); 7HN gene sequences identical to HN of NDV/chicken/Uganda/MU098/2011 (accession number: HG937564). +MDT and ICPI were performed
twice for NDV/chicken/Uganda/MU013/2011 with little difference; the average values shown in the Table.
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with the criteria defined by Diel et al. [7], we aimed at
(i) confirming the robustness of genotype V after the
addition of new F gene sequences, and (ii) redefining
sub-genotypes within genotype V. As shown on Figure 2a
and 2b, genotype V was clearly supported by the ML tree
topology and by a high bootstrap value (99, Figure 2a).
Phylogenetic analyses carried out on the basis of the first
375 nucleotides of the F gene confirmed the strains
genotypes (data not shown). Table 2 summarizes the evo-
lutionary distances between class II NDV genotypes. All
evolutionary distances between genotype V sequences and
their class II NDV counterparts (numbers in bold in
Table 2) were >10%, confirming the robustness of geno-
type V. Within genotype V, the East African viruses
seemed to cluster separately from sub-genotypes Va, Vb,
and Vc viruses (Figure 2a, node supported by a bootstrap
value of 99). The ML tree findings were confirmed by evo-
lutionary distances comparisons: distances between the
subgenotype Vd East African NDV viruses included in the
analysis and Va, Vb and Vc sub-genotypes ranged between
10 and 13% (Table 3), which is higher than the distance re-
quired for a new sub-genotype to be defined (3 to 10%,
[7]). The analysis of evolutionary distance between geno-
types was carried out considering the sub-genotype Vd as
a full genotype and showed distances ranging between
11.3 and 23.9% between Vd viruses and the 17 other geno-
types (11.3% between Vd and V; 23.9% between Vd and
XI, data not shown). However it seems difficult to con-
sider East African NDV viruses (Vd) as a distinct full
genotype when looking at the tree topography only.
We also compared the Uganda strains with the geno-
type Vd viruses from East Africa. The Ugandan strains
could only be differentiated from the Kenyan strains by
substitutions in the HN protein by only two amino acids
Y205F and A546V. However there were residues shared
by Kenyan and Ugandan strains at positions S440N and
T48A: half of the Uganda isolates shared the same amino
acids S440 and T48 with Kenyan isolates. The F-proteindid not have any specific residues that differentiated be-
tween the Ugandan and other genotype Vd East Africa
strains.
In an attempt to estimate whether the current vaccine
strain in use in Uganda could be effectively inducing
protective antibodies against the circulating field strains,
we compared the major neutralizing antibody epitopes
previously reported [11,12] within the F and HN pro-
teins between the Lasota vaccine strain and our field
isolates from this study. This revealed that all the
Ugandan and indeed the East Africa Vd isolates shared
similar residues D72, E74, A75, K78, A79, L343 and
151ILRLKESIAATNEAVHEVTDG171 in the F-protein with
the Lasota vaccine strain. In the HN protein, both the
Uganda strains and the Lasota vaccine strain also shared
similar neutralizing antibody epitopes residues; D287,
E347, D349, Y350, R353, K356, R513, I514 (except for 2
strains), S519, S521 and N569. The neutralizing epitopes
of the Ugandan strains however differed from the Lasota
strain at some residues. The Uganda strains had R333
(except one strain-MU069) and N569 while the Lasota
had K333 and D569.
Genetic diversity of NDV in Uganda
Low genetic diversity was observed among 2011 Ugandan
NDV strains with Kimura distances ranging from 0.0 to
2.6% and from 0.0 to 3.5% for the F and HN genes, re-
spectively; but also among known Ugandan NDV strains
(virus sequences available from 2001 and 2011 only) with
Kimura distances (on partial genes sequences) ranging
from 1.5 to 2.6% (comparison between our 2011 se-
quences and the partial F gene sequence of NDV/chicken/
Pallisa/0405/2001) and from 1.6 to 4.1% (comparison be-
tween our 2011 sequences and the partial HN gene se-
quence of 15 partial Ugandan 2001 NDV sequences) for
the F and HN genes, respectively.
Our study isolated from apparently health poultry in
live bird markets ND viruses that were velogenic in eggs


















































































































































Figure 2 (See legend on next page.)
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Figure 2 Phylogenetic trees (ML trees) of the fusion (F) gene of Ugandan Newcastle disease virus (NDV) isolates at the nucleotide
level. Partial F gene sequences are indicated with a “*” symbol after the strain name. A single representative virus was selected for strains with
identical nucleotide sequences: NDV/chicken/Uganda/MU001/2011 was identical to NDV/chicken/Uganda/MU004/2011 and NDV/chicken/
Uganda/MU005/2011; NDV/chicken/Uganda/MU026/2011 to NDV/chicken/Uganda/MU028/2011; and NDV/duck/Uganda/MU062/2011 to NDV/
chicken/Uganda/MU063/2011. The F sequences of our Ugandan NDV isolates were compared with A) all full F gene sequences available in
GenBank database: 1209 sequences, and B) the reference vaccine strain Lasota, a representative strain for each of the genotype V subgenotypes,
and all the East African NDV strains available in the database (indicated with an open circle).
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firmed by the ICPI which revealed that all the isolates
for which ICPI was done had values close to 2.0 (1.60-
1.86) with only one isolate (NDV/chicken/Uganda/
MU013/2011) with a value of 0.35. The high MDT value
and the cleavage site motif of NDV/chicken/Uganda/
MU013/2011 however indicated that it was also virulent.
Although fairly accurate and sensitive there could be
some possible differences in ICPI results related to the
execution or final dose that reaches the target site as
previously described [13]. The variations in virulence of
ND viruses are well known and although the use of
MDT provides well defined cut-off values for classifica-
tion for grouping the viruses into lentogenic, mesogenic
and velogenic strains, it has been indicated to be impre-
cise and unreliable and OIE recommends use of ICPI in-
dices above 0.7 by international agreement for purposes
of ND outbreak notification [5].
Traditionally, non-commercial poultry farmers have
recognized that introduction of birds from live bird mar-
kets was followed by Newcastle disease outbreaks. It is
only recently that virological studies showing that
healthy-looking birds in live bird markets carry virulent
ND viruses have come through to confirm this long
known belief [14,15]. While more and more genetic
studies of Newcastle disease are coming out from Africa,
many of them have been limited in number of isolates,
extent of the sequences analysed, regional as well in-
country representation.
A little more studies and genetic analysis of isolates from
West Africa have been done. Diverse genotypes of NDV
were reported in these studies [11,14-19] complementing
other studies in the rest of the world. In addition, genetic
diversity at the aa level observed among Western African
viruses by Snoeck et al. [11,15] is much higher than what
we observed in Uganda. More precisely, when we calcu-
lated the Kimura distance (at the nt level) for available
complete F gene sequences from Nigeria for example
(country in West Africa with most NDV sequence infor-
mation) within a single genotype it ranged between 0 and
4.6% for genotype XIVa (strains from 2007 to 2011 n = 15;
0 to 4.6% for 2009 strains alone, n = 12) and between 0
and 5.8% for genotype XVIIa (strains from 2006 to 2011
n = 38; 0.1 to 5.0% for 2009 strains alone, n = 21). This dif-
ference could be because (i) there are very few isolatesfrom East Africa that have been examined at the genetic
level [10,20,21] and for most of them only partial
sequences at the cleavage site of the fusion gene were ex-
amined but also because (ii) Nigeria is a much bigger
country than Uganda, with more complex poultry trade
with neighbors but also international trade. The Kimura
distance we observed in Uganda was indeed <2.5% for the
F gene between 2001 and 2011.
Until recently most of the classification of these vi-
ruses was based on the F-protein cleavage site partial
sequences and their restriction analysis [3] but this
method harbored inconsistencies for example in the evo-
lutionary distances between genotypes and subgenotypes
[20]. In the present study we used the new classification
system proposed by Diel et al. [7] for nomenclature and
classification of the class II ND viruses to classify our vi-
ruses and compare them with other East Africa strains
with full F gene sequence available in GenBank. Our
study confirmed the benefit of using this new classifica-
tion system for NDV strains but at the same time
highlighted some differences in the different genotyping
criteria; specifically the distance estimates percentages
and tree topology. In our current analysis, while most of
the East African NDV strains have a sufficient distance
estimate from the other genotype V strains to form a
new genotype, the tree topology analysis does not differ-
entiate them into a different genotype but rather groups
them among genotype V viruses (Figure 2). This high-
lights the importance of both distance estimates and tree
topology for NDV genotyping and suggests that criteria
used for genotyping may need to be updated in the
future.
The Ugandan viruses from our study clustered in
genotype V with most other NDV sequences from
Kenya and Tanzania that were available in GenBank for
analysis. Interestingly, there was very limited diversity
among our isolates, all of them clustering in genotype V.
Our strains also differed from the genotype Ia strains
identified in Tanzania (previously classified as lineage 1a)
[20], genotype II strains identified in Tanzania and Ethiopia
(previously classified as lineage 2) [20,22], genotype
IV strain identified in Sudan (previously classified as
lineage 3b) [23], genotype XIII isolates from Burundi
and Tanzania (previously classified as genotype VIIb or




























































































Figure 3 (See legend on next page.)
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Figure 3 Phylogenetic tree (ML tree) of the hemagglutinin-neuraminidase (HN) gene of Ugandan Newcastle disease virus (NDV)
isolates at the nucleotide level. The HN sequences of our Ugandan NDV isolates were compared with relevant virus sequences available in
GenBank database: the reference vaccine strain Lasota, all the East African NDV strains available in the database (indicated with an open circle), Ethiopian
strains, and a representative strain for each of the genotype V subgenotypes. Partial HN gene sequences are indicated with a “*” symbol after the strain
name. A single representative virus was selected for strains with identical nucleotide sequences: NDV/chicken/Uganda/MU001/2011 was identical to
NDV/chicken/Uganda/MU004/2011 and NDV/chicken/Uganda/MU005/2011; NDV/chicken/Uganda/MU007/2011 to NDV/chicken/Uganda/MU009/2011;
NDV/chicken/Uganda/MU026/2011 to NDV/chicken/Uganda/MU028/2011; NDV/chicken/Uganda/MU059/2011 to NDV/duck/Uganda/MU062/2011 and
NDV/chicken/Uganda/MU063/2011; NDV/chicken/Uganda/MU096/2011 to NDV/chicken/Uganda/MU099/2011 and NDV/chicken/Uganda/MU102/2011;
and NDV/chicken/Uganda/MU098/2011 to NDV/chicken/Uganda/MU105/2011.
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http://www.virologyj.com/content/11/1/173and Sudan [20,23], genotype VI isolates from Ethiopia
(as determined by the phylogeny carried out in the
present study), and genotype VIId isolates from Sudan
and Ethiopia [22,23] as well as South Africa strains [24]
(previously classified as genotype VIId). The most com-
mon virulent genotypes known to cause disease across
the world belonged to genotypes V, VI, VII and VIII
[25]. Genotype V in which our isolates fall is said to
have been most commonly isolated from Central and
North America and only three subgenotypes (Va, Vb
and Vc) have been described in the new classification
while the most common West Africa strains belong to
genotypes XIV, XVII and XVIII [11]. Our isolates did
not cluster with the three subgenotypes according to
the criteria proposed by Diel et al. [7], suggesting that
they belonged to a new subgenotype which we have
named subgenotype Vd.Table 2 Estimates of evolutionary distances (in number of su
genotypes of class II
Genotype (number of
sequences analyzed) I II III IV IX V VI
I (n = 113) 0.009 0.009 0.008 0.008 0.011 0.0
II (n = 128) 0.118 0.010 0.010 0.010 0.013 0.0
III (n = 9) 0.103 0.118 0.008 0.009 0.011 0.0
IV (n = 6) 0.101 0.115 0.074 0.008 0.010 0.0
IX (n = 25) 0.104 0.120 0.081 0.073 0.011 0.0
V (n = 124) 0.179 0.193 0.163 0.140 0.161 0.0
VI (n = 139) 0.161 0.179 0.149 0.120 0.148 0.144
VII (n = 312) 0.170 0.195 0.154 0.133 0.157 0.158 0.1
XII (n = 8) 0.139 0.154 0.125 0.097 0.121 0.131 0.1
VIII (n = 4) 0.104 0.109 0.118 0.114 0.114 0.185 0.1
X (n = 19) 0.177 0.188 0.161 0.115 0.151 0.206 0.1
XI (n = 4) 0.171 0.193 0.154 0.135 0.155 0.160 0.1
XIII (n = 27) 0.167 0.189 0.154 0.129 0.146 0.154 0.1
XIV (n = 52) 0.203 0.234 0.197 0.170 0.196 0.184 0.1
XVI (n = 4) 0.151 0.172 0.142 0.111 0.139 0.152 0.1
XVII (n = 54) 0.171 0.202 0.172 0.149 0.162 0.161 0.1
XVIII (n = 15) 0.176 0.189 0.163 0.145 0.155 0.159 0.1
The number of base substitutions per site from averaging over all sequence pairs b
diagonal, in italic font. Analyses were conducted using the Maximum Composite Lik
distribution (shape parameter = 1). All positions containing gaps and missing data wThe similarity or clustering of our isolates from the
present study and some of the Kenyan and Tanzanian
isolates might suggest cross border mixing of strains,
which may occur through uncontrolled cross border
trade of live birds carrying an endemic strain evolving
within the Uganda-Kenya-Tanzania region. This would
explain the difference between our isolates and the
Sudan and Burundi strains which are different, suggest-
ing limited mixing of the strains. The long time insur-
gency in Northern Uganda and South Sudan did not
allow free trade along these borders and could explain
this observation. While the difference with West Africa
strains is geographically understandable, the limited
number of isolates from countries in East Africa and un-
availability of full F gene sequences could have limited
fair comparison of the strains in the region. There could
therefore be more diversity than we could ascribe withbstitutions per site) over sequence pairs between
VII XII VIII X XI XIII XIV XVI XVII XVIII
10 0.012 0.010 0.008 0.013 0.011 0.011 0.013 0.011 0.012 0.012
12 0.014 0.011 0.009 0.015 0.014 0.013 0.017 0.013 0.014 0.013
10 0.012 0.010 0.010 0.013 0.012 0.011 0.014 0.011 0.013 0.011
09 0.011 0.008 0.010 0.010 0.011 0.010 0.012 0.009 0.011 0.011
10 0.012 0.010 0.010 0.012 0.012 0.011 0.014 0.011 0.012 0.011
09 0.010 0.009 0.013 0.014 0.011 0.010 0.012 0.010 0.011 0.010
0.009 0.008 0.011 0.013 0.008 0.008 0.011 0.009 0.010 0.009
24 0.010 0.013 0.015 0.009 0.009 0.011 0.011 0.010 0.009
06 0.119 0.011 0.013 0.009 0.008 0.011 0.009 0.010 0.010
66 0.175 0.151 0.014 0.013 0.012 0.015 0.012 0.013 0.013
97 0.212 0.181 0.185 0.015 0.014 0.017 0.013 0.015 0.015
14 0.103 0.114 0.173 0.211 0.007 0.010 0.011 0.008 0.008
21 0.105 0.115 0.173 0.203 0.096 0.009 0.010 0.008 0.007
50 0.140 0.151 0.208 0.250 0.126 0.126 0.013 0.010 0.010
38 0.154 0.118 0.157 0.191 0.150 0.141 0.180 0.012 0.011
36 0.127 0.134 0.182 0.216 0.114 0.112 0.127 0.164 0.008
22 0.119 0.127 0.178 0.208 0.104 0.101 0.125 0.159 0.104
etween groups are shown. Standard error estimate(s) are shown above the
elihood model. The rate variation among sites was modeled with a gamma
ere eliminated. Numbers in boldface refer to genotype V viruses.
Table 3 Estimates of evolutionary distances (in number of




Vd Va Vb Vc
Vd (n = 25) 0.011 0.008 0.010
Va (n = 45) 0.128 0.007 0.006
Vb (n = 33) 0.101 0.101 0.007
Vc (n = 5) 0.118 0.066 0.093
The number of base substitutions per site from averaging over all sequence
pairs between groups are shown. Standard error estimate(s) are shown above
the diagonal, in italic font. Analyses were conducted using the Maximum
Composite Likelihood model. The rate variation among sites was modeled
with a gamma distribution (shape parameter = 1). All positions containing gaps and
missing data were eliminated. Numbers in boldface refer to sub-genotype Vd.
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http://www.virologyj.com/content/11/1/173the limited strains sequences in GenBank. All our strains
were defined by the “112RRQKR*FV118” motif at the
cleavage site. These strains with valine at position 118
have been previously classified as lineage 3 [6] and this
motif is common among most genotype V and have been
reported in Madagascar [21] and other countries. How-
ever our isolates differ in this region where Madagascar
isolates that had “112RRRRR*FV118” motif at the cleavage
sites as compared to ours with RRQKR*FV motif,
although all were isolated from apparently healthy non-
vaccinated poultry. Previous studies have indicated that
isolates with valine at position 118 results accompanied
by substitution of the arginine by glutamine at position
114 resulted in reduction of viral replication and patho-
genicity of the viruses [26]. Although no evaluation
was done of the single I118V substitution without the
Q114R substitution in that study, our isolates that con-
tain the RRQKR*FV have been demonstrated to be
highly virulent in experimental studies although they
were isolated from apparently healthy poultry.
Genetic studies for NDV are not only important for
diagnostic and pathogenicity assessment but are also
becoming increasingly important in vaccine strain se-
lection and vaccine studies. Reports have alluded to
the possible challenges and implications for diagnosis
based on genetic differences in the matrix gene sup-
posed to be conserved across most strains and its im-
plications for the current molecular diagnostic tools
[16,25]. More important is the implication for vaccin-
ation which is the current best option for controlling
the disease. Several studies have demonstrated that
while Newcastle disease virus or APMV-1 viruses be-
long to the same serotype, they have diverse genotypes
that evolve independently and may impact vaccination
success. It has been demonstrated that vaccination
with heterologous vaccines often result in protection
but the birds still shed virulent viruses [27].
Neutralizing antibodies against fusion and hemagglutinin-
neuraminidase proteins play an important role in protectionagainst infection [28]. Differences in genotype between
vaccine and challenge strains does not hamper the ability
of vaccines to protect against disease but viral replication
and virus shedding still occurs [29]. However experimental
studies have shown that vaccination with genotypic hom-
ologous vaccines with challenge virus leads to less virus
shedding and therefore reduced virus transmission than
heterologous vaccines [29]. It was further demonstrated
that significant reduction in virus replication and virus
shedding with neutralizing antibodies was more efficient
with homologous vaccine strains although higher levels of
heterologous antibodies could also reduce transmission
[27]. Our present study revealed that neutralizing antibody
epitopes on the F protein of our Uganda strains and in-
deed most of the East Africa isolates were similar to the
Lasota vaccine strain which is the most commonly used
vaccine strain in Africa and were similar to most genotype
V strains both from Africa and elsewhere [11]. The substi-
tutions noted in the epitopes on HN protein and other dif-
ferences in the aa sequence that could differentiate them
from the closely related subgenotype Vd Kenyan strains
might suggest possible independent evolution of the
Ugandan strains.
The fact that we were able to isolate these highly
virulent viruses from apparently healthy-looking birds
indicates there was virus replication and shedding that
could result in virus transmission and could cause
outbreaks. This finding has important bearing on the
vaccination strains being used in Africa and provides
further data to explore genotype matched vaccines as
the most effective strategy to controlling Newcastle dis-
ease as has been suggested [27,28]. Indeed a vaccine
study was carried out with South African NDV strains
and showed cross-protection of birds with heterologous
challenge [30] and a recent ND vaccine efficacy study
using Lasota vaccine strain against field strains for West
Africa demonstrated protection although the birds still
shed virulent viruses [14]. This recent report and the
present study indicate that healthy-looking birds may be
protected from virulent viruses but continue to shed vi-
ruses that may cause disease in naïve populations. The
mechanisms behind the survival of velogenic virus in pro-
tected birds needs further investigation because it forms
part of an important solution to breaking the transmission
cycle of these viruses and hence definitive control of ND.
Conclusions
The present study represents the first Ugandan country-
wide genetic study of Newcastle disease viruses demon-
strating that highly virulent viruses are replicating and
being shed by apparently healthy poultry in live bird
markets. They potentially pose a serious risk for out-
breaks in the naïve non-commercial poultry populations.
It also provides evidence of a new subgenotype Vd of
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and Tanzania with implications for the control strategies
across the porous borders. While the neutralizing epi-
topes in these strains showed similarity with the Lasota
vaccine strain commonly used for vaccination in the re-
gion, the evidence of the replication and shedding of the
virulent viruses in apparently healthy birds requires
more research. Vaccine strains that could significantly




Tracheal and cloacal swabs were collected from do-
mestic birds from live bird markets in 1500 μl vials of
virus transport medium (VTM) across the country
with samples collected from representative districts
in each region (central, eastern, northern and western)
as shown in Figure 1. From each region, districts
were randomly selected as follows: central (Masaka,
Mukono, and Wakiso), eastern (Abim, Bugiri, Iganga,
Kotido, Kumi, Namutumba, and Soroti), northern (Apac,
Arua, Gulu, Koboko, Lira, and Nebbi), and western
(Kabale, Kabalore, Kasese, and Kisoro). From each of these
districts samples were collected from one major live bird
market. A total of 1,357 samples were collected with at
least 30 samples per selected daily or weekly animal
market. The specimens were collected within a 6 months
period: from January to June 2011. All samples were
transported in a liquid nitrogen dry shipper and stored
at −80°C until analyzed.
Virus isolation and identification
Each field sample was inoculated into 9-10-day old em-
bryonated eggs. Egg inoculation, incubation, candling
and virus harvesting were conducted in accordance
with the OIE Manual of Standards for diagnostic tests
and vaccines [5]. Allantoic fluid was harvested from the
eggs and ND virus screened for by hemagglutination
(HA) assay. The HA positive samples were subjected toTable 4 Primer sets used for PCR amplification of F and HN g
Gene Forward primer (5′ to 3′) R









2modified from [32].hemagglutination inhibition (HI) tests using reference
antisera (PMV-1 monoclonal antibodies or antibodies
generated in-house in rabbits against Lasota NDV vac-
cine strain, boosted at weekly intervals) and 0.5%
chicken red blood cells for NDV confirmation. The HA
and HI assays were carried out by the microtiter
methods as previously described [31]. Virus stocks were
stored at −70°C until further use.
Newcastle disease virus confirmation by RT-PCR
Viruses were further confirmed by PCR before sequen-
cing. Viral RNA was extracted from all samples by using
the QIAamp Viral RNA mini kit (Qiagen) according to
the manufacturer’s directions. RT-PCR of the extracts
was performed by using a Qiagen One-Step RT-PCR kit
according to the manufacturer’s instructions, with the
following NDV fusion gene primers FOP1: 5′ TACACCT
CATCCCAGACAGGGTC 3′ and FOP2: 5′ AGGCAGG
GGAAGTGATTTGTGGC 3′ [32]. The 25-μl reaction
volume contained 5 μl of 5x RT-PCR buffer, 11 μl of
RNAse-free H20, 1 μl of 10 mmol/L dNTPs, 1.5 μl of
10 μmol/L of each primer, 2 μl of 50 mMMgCl2, 1 μl of en-
zyme mix (Taq DNA polymerase and reverse transcriptase),
and 2 μl of viral RNA extract. Amplification was carried
out in an Applied Biosystems Veriti 96-well thermocycler
with a single reverse transcription step of 50°C for 30 min,
a denaturation of the RT (95°C) for 15 min, followed by
forty cycles with 30-sec denaturation at 95°C, 30 sec of pri-
mer annealing at 58°C, 1 min of extension at 72°C, and a
final extension for 10 min at 72°C. The samples (including
a known positive control) were then separated on a 1%
agarose gel with a 100-bp marker. The primers amplified a
532-bp segment of the fusion gene in NDV–positive sam-
ples; this product was visualized and documented in a
Biorad Gel Doc XR imager.
Biological characterization
Biological characterization of the isolates was under-
taken to classify the pathotypes of the isolates according
to OIE [5]. This included the mean death time (MDT)enes of Ugandan NDV isolates
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a specific-pathogen-free source (Lohmann Tierzucht,
Cuxhaven, Germany) inoculated by the allantoic cavity
route. The MDT was determined by inoculating a stand-
ard dose of 1 × 106 50% egg infectious doses [EID50]
into the allantoic cavities of 9- to 11-day-old embryonat-
ing specific-pathogen-free eggs. The eggs were incubated
at 37°C and candled twice daily (early morning and late
afternoon) for 7 days, and the time of embryo mortality
was recorded. The MDT for a minimum lethal dose was
interpreted as the mean time in hours for the embryo
death in the highest dilution at which all eggs died. The
isolates were classified as: velogenic viruses if they killed
the embryos in fewer than 60 hours; mesogenic if they
killed the embryos in 60 to 90 hours; avirulent viruses if
they failed to kill the embryos at all. The selected isolates
were also tested for virulence in one-day old specific-
pathogen-free chicks by intra-cerebral injection of
virus. The results were converted into an intra-cerebral
pathogenicity index (ICPI) that varied from zero to a
maximum of 2.0 for velogenic viruses as described [5].
In addition, the pathotypes were further examined by
sequencing of the F0 protein cleavage site motif as
described below.
Sequencing of the fusion (F) and hemagglutinin-
neuraminidase (HN) genes
A total of 49 representative isolates were selected for se-
quencing, among which 19 were selected for full F and
HN genes sequencing. In addition to the 19 full F and
HN sequences, an extra 10 full F and 19 full HN gene
sequences were successfully obtained. For the rest of the
65 isolates, only partial sequencing of the cleavage site
was done to determine their amino sequence at this site
for pathotyping. To amplify full F and HN genes, cDNA
was first generated with random hexamers and revert aid
H minus reverse transcriptase (Fisher, Illkirch, France)
following the instructions of the manufacturer. PCR was
carried out for individual gene fragments with primers de-
scribed in Table 4, using Taq DNA polymerase (Qiagen).
The gene fragments were amplified in an Applied Biosys-
tems GeneAmp PCR system 9700 thermocycler with the
following touchdown PCR program: 2 minutes at 95°C,
5 cycles with 30s at 95°C, 30s at 58°C, 1 min at 72°C; 30 -
cycles with 30s at 95°C, 30s at 56°C, 1 min at 72°C; 5 cycles
with 30s at 95°C, 30s at 54°C, 1 min at 72°C; and further
extension for 10 min at 72°C. The different fragments
were run on a 1% gel and purified by gel purification kits
(Qiagen). Sanger sequencing method was carried out on
all the segments using the same primers as used for the
PCR. Sequencing was performed on a 3130XL Applied
Biosystems capillary sequencer at the Plateau de Génomi-
que GeT-Purpan, UDEAR UMR 5165 CNRS/UPS, CHU
PURPAN, Toulouse, France.Sequence analysis
The sequences obtained were aligned using Clustal W
and edited using Bioedit Software version 5.0.9 [33].
Phylogenetic analysis was performed using the MEGA
version 5.05 program [34]. The number of bootstrap
replications was set to 500 (for maximum likelihood
(ML) analyses) or 1,000 (for Neighbor-Joining (NJ) ana-
lyses), and bootstrap values above 50 were labeled on
major tree branches for reference. The Ugandan virus
strains were clustered on the basis of nucleotides, and
only dominant clusters were used to infer phylogenetic
relationships. Genotype and subgenotype classification
was performed as described by Diel et al., [7]. The ana-
lysis included all available full sequences in GenBank or
for Figures 2B and 3 all sequences from East Africa in
GenBank and the sequence of the reference vaccine
strain, Lasota.
Accession numbers
The complete gene sequences of the isolates analyzed in
this study were deposited in GenBank with accession
numbers [HG937535 to HG937591]. The isolates with
identical sequences were not deposited in the GenBank
instead they were represented by one sequence and they
have been indicated in the phylogenetic tree legends.
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